HARRISBURG, Pa., Nov. 7, 2016 /PRNewswire-USNewswire/ -- Department of Health Secretary Dr. Karen Murphy today asked for public input on the proposed temporary regulations for laboratories that would be responsible for testing medical marijuana.
The proposed regulations can be viewed here, and will be open for comment until
"We're especially looking for comments from the laboratory community to help us develop regulations that protect the integrity of the medical marijuana testing process," Secretary Murphy said. "As we move forward in this ground-breaking effort, we want to make sure that patient safety is paramount, and laboratories are essential to meeting that goal. These regulations are designed to ensure we have a safe and responsible process in place."
The proposed temporary regulations outline:
A survey also is available on the department's website here for patients who will be eligible for the Medical Marijuana Program to help ensure the program will meet their needs. The survey will be available on the department's website until 5:00 PM on Friday, November 18.
The medical marijuana program was signed into law by Governor Tom Wolf on April 17, 2016. Since that time, the department has:
Full implementation of the program is expected to take between 18 and 24 months. The program will provide access to medical marijuana for patients who are Pennsylvania residents under a physician's care for the treatment of a serious medical condition as defined by Act 16.
Questions about the medical marijuana program can be emailed to RA-DHMedMarijuana@pa.gov. Information is also available at www.health.pa.gov.
MEDIA CONTACT: April Hutcheson, 717-787-1783
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pennsylvania-department-of-health-seeks-public-input-on-medical-marijuana-draft-temporary-regulations-for-laboratories-300358645.html
SOURCE Pennsylvania Department of Health
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All